Dr. Sakina Rizvi received her PhD in the Faculty of Pharmacy and Collaborative Program in Neuroscience at the University of Toronto. She has over 10 years of experience in psychiatry across the areas of neuroimaging, neuropsychology, psychotherapy, pharmacology, and scale development; with a focus in Major Depressive Disorder. Currently, Dr. Rizvi is a Scientist in the Arthur Sommer Rotenberg (ASR) Suicide and Depression Studies Program at St. Michael’s Hospital and Assistant Professor in the Department of Psychiatry, University of Toronto. Her research within the ASR program aims to characterize the neurobiology of suicide risk and treatment resistant depression, primarily through the use of fMRI and PET neuroimaging, and to develop and test novel therapeutic strategies. Within her biomarker research, she is evaluating brain reward mechanisms as predictors of treatment outcome and as a path for intervention. In addition, as Co-Lead for the Ontario Depression Network, her goal is to promote mental illness advocacy, education and resource building across Ontario.